Sensitive genotyping of mutations in the EGFR gene from NSCLC patients using PCR-GoldMag lateral flow device
Abstract Epidermal growth factor receptor (EGFR) mutations predict better outcomes with EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer (NSCLC). Most common activating mutations include in-frame deletion in exon 19 and L858R substitution in exon 21, which account for >...
Guardado en:
Autores principales: | Xian-Ying Li, Chao Zhang, Qin-Lu Zhang, Juan-Li Zhu, Qian Liu, Ming-Wei Chen, Xue-Min Yang, Wen-Li Hui, Ya-Li Cui |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ac6a5c9980654cd8ab230d3fecbc3679 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
por: Wen M, et al.
Publicado: (2018) -
Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations
por: Zhang SS, et al.
Publicado: (2021) -
Detection of EGFR mutation in plasma using multiplex allele-specific PCR (MAS-PCR) and surface enhanced Raman spectroscopy
por: Xiaozhou Li, et al.
Publicado: (2017) -
Poor prognosis of NSCLC located in lower lobe is partly mediated by lower frequency of EGFR mutations
por: Hyun Woo Lee, et al.
Publicado: (2020) -
Deciphering mechanisms of acquired T790M mutation after EGFR inhibitors for NSCLC by computational simulations
por: Bin Zou, et al.
Publicado: (2017)